Screener
Syndax Pharmaceuticals SNDX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.06B.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's market capitalization?
- Syndax Pharmaceuticals (SNDX) reported market capitalization of $2.06B in Q1 2026.
- How has Syndax Pharmaceuticals's market capitalization changed year-over-year?
- Syndax Pharmaceuticals's market capitalization increased by 95.0% year-over-year, from $1.06B to $2.06B.
- What is the long-term trend for Syndax Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's market capitalization has grown at a 8.8% compound annual growth rate (CAGR), from $1.2B to $1.83B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Syndax Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude